Anti-VEGF drugs are administered intravitreally to treat wet age-related macular degeneration (wet AMD). They block abnormal new blood vessel growth while also preventing their leakage. Anti-VEGF therapy has been shown

Macular degeneration is a condition in which blurry vision in the center of your visual field makes it more difficult to drive, recognize faces or read. Degeneration occurs when fluid

Stargardt disease affects the macula, an area of the retina with the highest concentration of light-sensing cells. Although there is no cure, there are ways to slow its progress and

Age-related macular degeneration (AMD) is an eye condition commonly experienced as people age, typically leading to progressive loss of vision over time. Although AMD cannot be prevented, steps can be

Stargardt disease is an inherited form of macular degeneration that affects the macula – the area of retina responsible for central vision and color perception – typically appearing during childhood

Macular degeneration causes central vision to decline, diminishing your ability to see fine details in objects and people’s faces while not impacting side (peripheral) vision. Age-related macular degeneration can be

AMD (Age-Related Macular Degeneration) is a progressive disease that impacts your central vision while leaving peripheral (side) vision unaffected. Regular eye exams should be scheduled in order to detect changes

What are macular degeneration injections? An intravitreal injection is a medical procedure in which medication is injected directly into the back of your eye by a doctor and used to